Anthera Pharmaceuticals, Inc. (ANTH: Quote) said Wednesday that it plans to offer and sell shares of its common stock in an underwritten public offering.
The company expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering to cover over-allotments, if any.
The company said it plans to use the net proceeds from the offering for general corporate purposes.
Anthera said offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
Piper Jaffray & Co. and Leerink Swann LLC are acting as joint book-running managers in the offering.
Click here to receive FREE breaking news email alerts for Anthera Pharmaceuticals, Inc. and others in your portfolio
by RTT Staff Writer
For comments and feedback: email@example.com